Cellectis SA (XPAR:ALCLS)
€ 1.48 -0.02 (-1.33%) Market Cap: 148.14 Mil Enterprise Value: -14.65 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 44/100

Q3 2019 Cellectis SA Earnings Call Transcript

Nov 07, 2019 / 01:00PM GMT
Release Date Price: €11.5 (+1.59%)
Operator

Greetings and welcome to Cellectis Q3 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Simon Harnest, Vice President, Strategy and Finance. Please go ahead.

Simon Harnest
Cellectis S.A. - VP of Corporate Strategy & Finance

Thank you, [Rob]. And thank you, everyone. Welcome to Cellectis's Third Quarter 2019 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks are André Choulika, our Chairman and Chief Executive Officer; and Eric Dutang, our Chief Financial Officer.

Yesterday evening, Cellectis issued a press release reporting our financial results for the third quarter ended September 30, 2019. This press release is available on our website at cellectis.com.

Just as a reminder, we will make forward-looking statements regarding financial outlook in addition to regulatory and product development plan. These statements are subject to risks and uncertainties that may cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot